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ABSTRACT
T-cell receptor (TCR) V (TRAV) and V (TRBV) chains provide the T-cell specificity for recognition of
major histocompatibility complex (MHC)-bound antigens. However, there is limited information on the
diversity of TRAV use within an antigen response. Previous investigation of CD4 T-cell–mediated graft-
versus-host disease (GVHD) in the minor histocompatibility antigen–mismatched C57BL/6 (B6)¡BALB.B
irradiated murine model determined that V11 T cells were associated with disease severity. Polymerase
chain reaction (PCR)-based complementarity-determining region 3 (CDR3)-sized spectratype analysis of B6
V11 T cells from the spleens of recipient BALB.B mice undergoing GVHD indicated biased use within the
V6, 9, 13, 14, 18, and 22 families. To probe deeper into this limited V response, the current study was
undertaken to further define TRAV-J (TRAJ) nucleotide sequences found in host-presensitized B6 V11 T
cells proliferating in response to in vitro stimulation with BALB.B splenocytes. Using the nonpalindromic
adaptor PCR method, we found dominant use of the TRAV13–TRAJ16 transcript combination. Then, using
laser capture microdissection, we found use of the identical TRAV–TRAJ nucleotide sequence in areas
dominated by infiltrating V11 CD4 T cells during the development of GVHD in both the rete-like
prominences of the dorsal lingual epithelium and the ileal crypts of the small intestine.
© 2007 American Society for Blood and Marrow Transplantation
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(NTRODUCTION
The relative contribution of the  and  chains,
articularly the T cell receptor (TCR) V (TRAV)
nd V (TRBV) regions, to the diversity and speciﬁc-
ty of the T-cell receptor (TCR) remains controver-
ial. Although several studies have indicated that the 
hain dictates recognition of self–major histocompat-
bility complex (MHC) molecules during MHC-re-
tricted responses [1-5], other investigations have also
ound a signiﬁcant role of the  chain in peptide
ecognition [3,6,7]. A crystal structure solution of a
CR interacting with a peptide–MHC II complex
evealed that TRAV actually made more peptide con- macts than TRBV [8], and studies using single - or
-chain transgenic mice have indicated that most T
ells responding to speciﬁc antigens could use various
chains but only 1  chain [9-14]. Thus, it is of
nterest to also determine the role of the TCR  chain
n alloantigenic recognition by donor T cells in bone
arrow transplantation models, particularly as it re-
ates to the development of graft-versus-host disease
GVHD).
We previously investigated TCR diversity during
D4 T-cell alloresponses in murine acute GVHD
irected to multiple minor histocompatibility antigen
miHA) differences using the B6¡BALB.B H2b-
atched strain combination [15-17]. In this lethally
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C. G. DiRienzo et al.266rradiated model, donor B6 CD4 T cells alone can
ause severe and lethal GVHD, characterized by
eight loss, diarrhea, and tissue injury in the skin,
ntestine, and liver [17-19]. The T-cell response was
nalyzed by polymerase chain reaction (PCR)-based
CR V CDR3-sized spectratyping and found to be
arked by a limited, yet heterogeneous TRBV use
20,21]. Among the 11 V families used, V2 and
11 were subsequently determined to be most im-
ortant for the severity of GVHD, in that combined
ransfer of only these 2 V families was able to cause
high level of mortality in BALB.B recipients, and
heir selective deletion from a donor T-cell inoculum
llowed for signiﬁcantly improved survival [22]. Fur-
her experiments have also indicated that the B6
D4V11 T cells alone are capable of mediating
evere GVHD [23], and sequence analysis of the
kewed CDR3-sized band in the CD4V11 re-
ponse identiﬁed the dominant clonal speciﬁcity in-
olved as using the J2.5 sequence [22]. To focus on
he V use, B6 CD4V11 T cells were isolated
rom the spleens of recipient BALB.B mice undergo-
ng GVHD, and analyzed by the V CDR3-sized
pectratype approach. We found skewing indicative of
estricted responses in the V6, 9, 13, 14, 18, and 22
amilies [23].
The current study was undertaken to further de-
ne TRAV use in the B6 CD4V11 T-cell re-
ponse against BALB.B miHA. Using the nonpalin-
romic adaptor (NPA)-PCR method, we found
ominant use of TRAV13 in combination with the
RAJ16 chain transcript. Then, using laser micro-
issection (LMD), we found use of the identical
RAV-TRAJ nucleotide sequences in areas domi-
ated by inﬁltrating CD4V11 T cells during
evelopment of GVHD in both the rete-like promi-
ences of the dorsal lingual epithelium and the ileal
rypts of the small intestine. These data indicate
ighly restricted TRAV use by CD4V11 T cells
nvolved in GVHD in this model.
ATERIALS AND METHODS
ice
C.B10/LiMcdJ (BALB.B; H2b) and C57BL/6By
B6; H2b) mice were purchased from Jackson Labo-
atory, Bar Harbor, Maine. BALB.B mice were also
red in our own colony. Male mice, aged 6–12 weeks,
ere always used as donors, whereas both female and
ale mice, aged 8–12 weeks, were used as recipients.
he mice were housed in a pathogen-free environ-
ent in autoclaved microisolator cages and provided
ith autoclaved food and water ad libitum. For lethal
rradiation exposure, the mice were given 10 Gy of
otal body irradiation (TBI) from a Mark I model 68A
37Cs source (JL Shepherd, San Fernando, CA). The 4se of the animals was approved by the Institutional
nimal Care and Use Committees of both Thomas
efferson University and Hackensack University Med-
cal Center.
edia
Lymphocytes, isolated by homogenization of
pleens and lymph node (LN) and bone marrow (BM)
ells, extracted from femurs, were suspended in phos-
hate-buffered saline (PBS; BioWhittaker, Walkers-
ille, MD) containing 0.1% bovine serum albumin
BSA; Sigma, St Louis, MO) (PBS-BSA). For cultur-
ng, lymphocytes were suspended in RPMI 1640 me-
ia containing 50 U/mL of penicillin, 50 g of strep-
omycin sulfate, 2 mmol/L of L-glutamine (all from
ediatech, Herndon, VA), 10% fetal bovine serum
FBS; Sigma), 50 mol of 2-mercaptoethanol (Life
echnologies, Gaithersburg, MD), and 1 mmol of
odium pyruvate (Fisher Scientiﬁc, Fair Lawn, NJ),
ollectively termed “complete media.” PBS-BSA and
.01% NaN3 (FC buffer) was used for analysis of cells
y ﬂow cytometry and for cell separation. All antibod-
es (Ab’s) used for cell subset depletions were resus-
ended in PBS-BSA.
reparation of Donor Cells and GVHD
B6 mice were immunized with 2  107 BALB.B
plenocytes intraperitoneally (i.p.), and spleens and
N were harvested 17–21 days later. The tissues were
omogenized and the cells resuspended in Gey’s bal-
nced salt solution containing 0.7% NH4Cl to lyse
rythrocytes. B cells were removed using a panning
echnique on a Petri dish coated with goat anti-mouse
gG antibody (1:200 dilution; Cappel-Organon
eknika, West Chester, PA) for 1 hour at 4°C. The
onadherent-enriched T-cell population was then in-
ubated with rat IgM anti-CD8 monoclonal Ab (mAb)
.168 [24] at 1:100 dilution along with guinea pig
omplement (1:6 dilution; Rockland, Boyertown, PA)
or 45 minutes at 37°C to enrich for CD4 T cells.
M was extracted from femurs of primed B6 mice,
uspended in PBS-BSA, and depleted of T cells by
reatment with anti–Thy-1 mAb (J1j [25]) and com-
lement for 45 minutes at 37°C. The remaining anti–
hy-1–treated BM (ATBM) cells were conﬁrmed to
ave 0% T cells by ﬂow cytometry. Donor ATBM
ells (2  106), along with enriched (97%–99%)
D4 T cells (1.7–2  107) were injected with PBS
ntravenously (i.v.) through the tail vein into lethally
rradiated (10 Gy) BALB.B recipients.
arboxyfluorescein Diacetate Succinimidyl Ester
abeling and Cell Culture
B6 mice were immunized i.p. and boosted with
 107 BALB.B splenocytes each on days 0, 21, and
2. Spleens and LN were harvested on day 63. The
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V Use in GVHD 267ells were enriched for CD4 T cells, as described
bove, suspended in PBS (2.5  107/mL), and labeled
ith 1.5 mol/L of carboxyﬂuorescein diacetate suc-
inimidyl ester (CFSE; Molecular Probes, Eugene,
R) for 10 minutes at 37°C, as described previously
26]. The CFSE-labeled B6 CD4 T cells were
ashed in complete media 4 times at 4°C and cultured
n 96-well round-bottomed plates (2.5  105 cells/
ell) along with irradiated (30 Gy) T-cell–depleted
ALB.B splenocytes at a 1:2 ratio, respectively (3 days;
% CO2; 37°C). Mimosin (300 mol; Sigma) was
dded to the wells of the control group to inhibit cell
roliferation.
reparation of RNA and cDNA
The in vitro BALB.B-stimulated CFSE-labeled
6 CD4 T cells were pooled from the plates, washed
times with FC buffer, and sorted on a MoFlo high-
peed cell sorter (Dako Cytomation, Carpinteria, CA),
ased on CFSE intensity, CD4, and V11 expression.
FSECD4V11 cells were collected directly into
he cell lysis buffer, and RNA was extracted according
o the manufacturer’s instructions (RNA Easy Kit;
iagen, Valencia, CA). Murine primers for cDNA
ynthesis and the protocol for the ampliﬁcation of
DNA were as described previously [27,28], with
ome minor modiﬁcations. Brieﬂy, Superscript III
irst-Strand Synthesis Super Mix (Invitrogen, Carls-
ad, CA) was used with a NotI-C3 gene-speciﬁc
rimer for ﬁrst-strand synthesis. After second-strand
ynthesis, the cDNA had a nonpalindromic double-
tranded adaptor ligated onto both blunt ends by
vernight incubation with T4 DNA ligase (1.4 U;
nvitrogen). NotI enzyme (7.5 U; Promega; Madison,
I) was added for restriction digestion for 3 hours at
7°C. The digested product was placed into a Min
lute PCR puriﬁcation column (Qiagen) to eliminate
esidual traces of enzyme. PCR was performed using
high-ﬁdelity Platinum Pfx DNA polymerase en-
yme (Invitrogen), with the ﬁrst round using mC2
nd EcoRI-XmnI primers, followed by 35 rounds of
mpliﬁcation. The PCR products were placed into a
in Elute PCR puriﬁcation column to remove
races of excess PCR buffers, then subjected to a
econd round of PCR using mC1 and EcoRI-
mnI primers in 35 rounds of ampliﬁcation. PCR
roducts were run on a 1.5% agarose gel, and
ands  150–700 base pairs (bp) in size were gel-
uriﬁed using a Qiagen gel puriﬁcation kit. Puriﬁed
roducts were ligated directly into the pGem T-
asy vector system (Promega) and transformed into
H5 Eschirichia coli. White colonies were selected,
nd DNA was extracted using a Qiagen Miniprep
it and sequenced on an Applied Biosystems ABI
rism 377 DNA sequencer. vmmunohistochemistry
Tongue and intestinal tissues were harvested from
rradiated BALB.B recipients 15 days after transfer of
6 ATBM and host-primed B6 CD4 T cells. Half of
he organ samples were collected in 10% phosphate-
uffered formalin (Fisher Scientiﬁc) and embedded in
arafﬁn for routine hematoxylin and eosin staining,
hereas the remaining tissues were embedded in op-
imal cutting temperature (OCT) medium (Miles
aboratories, Elkhart, IN) and snap-frozen in liquid
itrogen.
Staining was performed as described previously
29]. Brieﬂy, frozen sections were cut into 5-m-thick
ections at 20°C, air-dried overnight, ﬁxed in cold
cetone for 5 minutes, and air-dried once again. The
ections were then incubated with PBS containing 5%
SA and 0.1% Tween-20 (PBS-BSA/Tween), fol-
owed by goat blocking serum, and stained with ﬂuo-
escein isothiocyanate (FITC)-labeled anti-murine
11 or V5 mAb, or with FITC-IgG control Ab (all
rom Pharmingen and diluted 1:50 in PBS-BSA/
ween) for 1 hour at room temperature. Secondary
bs were biotin-conjugated rat anti-mouse IgG and
at anti-FITC (Vector Labs, Burlingame, CA), all di-
uted at 1:200 in PBS-BSA/Tween. Slides were devel-
ped using a biotin-avidin-horseradish peroxidase
HRP) ABC kit along with peroxidase (NovaVector
ed; Vector Labs). Sections were counterstained with
ayer’s hematoxylin solution.
MD and DNA Extraction
Frozen lingual and intestinal sections were cut,
b-stained, and counterstained as described above,
ut were placed uncoverslipped on vinyl acetate-
oated slides (Leica Microsystems, Bannockburn, IL).
Leica AS LMD instrument was used to target and
apture speciﬁc areas in the tissues, which were then
laced into the caps of 0.2-mL tubes containing 10 L
f 1  PCR buffer and 0.5 mg/mL of proteinase K
Fisher Scientiﬁc). The samples were heated for 1
our at 50°C, and proteinase K was inactivated at
5°C for 10 minutes.
CR Amplification
Primers used for multiplex PCR were designed
sing the Primo Multiplex 3.4 program (Chang Bio-
cience, Castro Valley, CA). This program designed
rimers that did not form primer–primer dimers, and
ach primer was tested individually before use. DNA
xtracted from each LMD section was added to a
ultiplex PCR mixture containing 1 PCR buffer,
latinum Pfx DNA polymerase enzyme (Invitrogen),
0 mmol MgCl2, 20 mol of each primer, and a total
f 800 mol dNTPs (200 7 m;mol each of dATP,
TTP, dCTP, and dGTP; Invitrogen) in a 30-L
olume. DNA was ampliﬁed for 40 cycles using the
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C. G. DiRienzo et al.268ollowing program: 94°C for 5 minutes, 60°C for 1
inute, 72°C for 1 minute, and 72°C for 4 minutes.
ultiplexed PCR products were run on a 3% agarose
el, gel-extracted, and then cloned into the pGem
-Easy vector (Promega). DNA was extracted from
hite colonies and sequenced as described above. Se-
uences were compared with sequences found in the
nternational ImMunoGeneTics (IMGT) database.
Primers, 5= to 3=, were as follows:
RAV13–TRAJ16 (69 bp): Forward, ATCACA-
GACTCAGGCACTTATC; reverse, CCCTGGC-
CAAAAACCAGCTTC
RAV13–TRAJ17 (79 bp): Forward, GGCACT-
TATCTCTGTGCCCTC; reverse, AGCACCC-
TGGTTCCGATTCC
D4 (285 bp): Forward, AGGGGCCACCACTT-
GAACTAC; reverse, AGCAGATTGTCCAGG-
GACACC.
MGT Database and Sequence Alignments
The IMGT database and tools (IMGT/V-
UEST; available at http://imgt.cines.fr/) were used
o align TRAV and TRAJ sequences found in the
FSE and LMD experiments [30-33]. CLUSTALW
ultiple sequence alignments were done using the
nline Biology Workbench (http://workbench.sdsc.
du) [34,35].
ESULTS
dentification of V11 T Cells in GVHD
arget Organs
To examine TRAV use within a GVHD-rele-
ant TRBV CD4 T-cell family, focus turned to
he V11 family, which was previously found to be
ssociated with severe GVHD in the miHA-dispar-
te B6¡BALB.B irradiated strain combination [22].
athological analyses using this model had indi-
ated that the BALB.B intestine, particularly the distal
leum, was targeted by donor B6 CD4T cells [20]. In
ddition, in the dorsal lingual epithelium of the mu-
ine tongue, the primary targets of T-cell–mediated
njury during GVHD were cytokeratin 15 epithelial
ells residing in structures called rete-like promi-
ences (RLPs), which resemble human skin rete
idges [36-38]. Initial experiments were conducted to
etermine whether CD4V11 T cells inﬁltrated
he gut and lingual target tissues of GVHD, and
hether their level of involvement varied. GVHD was
nduced by i.v. transfer of 2  107 B6 CD4 T cells
nd 2  106 ATBM cells into lethally irradiated (10
y) BALB.B recipients. At days 10 or 15 posttrans-
lantation, mice that received B6 ATBM cells exhib-
ted no histological signs of GVHD (eg, mononuclear
nﬁltration in either the lingual or intestinal tissues
data not shown]). In contrast, recipients of B6 CD4 mcells exhibited cellular inﬁltration in the dorsal
ingual epithelium by day 10 (Figure 1A) and ex-
anded inﬁltration on day 15 (Figure 1B). The ileal
rypts of intestinal tissues exhibited low-level inﬁltra-
ion on day 10 (Figure 2A), becoming more evident by
ay 15 (Figure 2B). Staining with V11-speciﬁc mAb
llowed detection of numerous inﬁltrating cells within
he RLP in the lingual tissues at day 10 ( 50% of the
ononuclear cell component; Figure 1C), with higher
umbers at day 15 (Figure 1D). Following a similar
attern, the intestinal tissues exhibited some V11
-cell inﬁltration on day 10 (Figure 2C), with an
ncreased amount on day 15 (Figure 2D). Because the
5 family was never found to be involved in GVHD
evelopment in this model at any time point, V5
Ab staining was used as the control for nonspeciﬁc
-cell inﬁltration [22]. V5 cells were not found in
ither the lingual (inset, Figure 1D) or the intestinal
inset, Figure 2D) sections, suggesting selective T-cell
nﬁltration into these tissues. Furthermore, sections
rom the tongue (Figure 1E, F) and intestine (Figures
E, F) of irradiated syngeneic B6 recipients of B6
D4 T cells did not exhibit V11 T-cell inﬁltra-
ion at either day 10 or day 15. Taken together, these
ata indicate that V11 T cells selectively inﬁltrate
oth lingual and intestinal tissues during the GVHD
esponse.
equencing Sorted Divided CD4V11 T Cells
n the B6¡BALB.B Response
The identiﬁcation of V11 T cells within the
ingual and intestinal inﬁltrates of BALB.B recipients
llowed us to investigate the corresponding TRAV
iversity in this physiologically relevant TRBV popu-
ation. The V11 T-cell family constituted 	 2.8%
f the naive B6 CD4 T-cell population [39]. To
peciﬁcally expand the numbers of anti-BALB.B
iHA-speciﬁc B6 T cells, B6 mice were serially sen-
itized with BALB.B splenocytes. At the end of the
ensitization period (63 days), B6 CD4 T cells were
solated from pooled spleen and LN of the sensitized
ice, labeled with CFSE to allow detection of divid-
ng cells [20,26], and cultured with irradiated (15 Gy)
-cell–depleted BALB.B splenocytes. After 3 days of
ncubation, CFSElow/negative CD4V11 T cells
ere sorted by ﬂow cytometry of the culture to isolate
he speciﬁc cells that had divided in response to miHA
timulation (Figure 3). A signiﬁcant number of the
rimed V11 T cells appear to have proliferated
apidly, as might be expected for memory T-cell re-
ctivation.
To determine the TRAV nucleotide sequence di-
ersity of the sorted CFSElow/negative CD4V11 T
ells, NPA-PCR ampliﬁcation was performed [27,28].
his technique allowed for ampliﬁcation of TRAV
RNA with unknown 5= ends. Because of the widely
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V Use in GVHD 269arying TRAV sequences between and within haplo-
ypes, subtle subfamily differences can be seen at the
ucleotide level [4,40]. NPA-PCR can identify TRAV
ucleotide sequences in the responding population
ithout skewing results by selecting for particular 
hain sequences or subfamilies. Using seminested
CR, products were ampliﬁed from 150 bp to 700
p, and the bands were cloned into a vector. Many of
he bands were faint and could not be visually re-
olved, but the brightest bands were found to be
200 bp in size, suggesting that most of the TRAV
equences were around this band size. Once the
loned sequences were analyzed and aligned using a
LUSTALW program, TRAV nucleotide conserva-
ion between the 12 sequences was evident (Figure
igure 1. Evolution of B6¡BALB.B GVHD in lingual epithelium
ymphocytes within the superﬁcial submucosa and epithelium. T
ifferentiated from the larger, more open nuclei of the squamous
ymphocytes increase in number by day 15, when they become m
poptosis (arrow; inset is B6¡B6 d15 control). (C, D) Immunohisto
ote the tendency of these cells to associate with target cells in the
or V5 in adjacent section]. (E, F) The B6¡B6 control tongue faA). Separating the sequences and aligning them with qhose that were similar and in frame revealed that they
sed TRAV13 along with 2 dominant TRAJ se-
uences. Five in-frame sequences contained TRAJ16
Figure 4B), and 5 other out-of-frame sequences con-
ained TRAJ17. Sequences containing TRAJ17 had 13
-region nucleotide additions, resulting in an out-of-
rame sequence. Sequences containing TRAJ16 were
n-frame and contained an N-region that contained a
ryptophan (W) surrounded by 2 alanines (A). The
ther 2 sequences contained TRAJ43 and TRAJ16
egions, but their TRAV regions could not be aligned
ecause the sequence was out-of-frame and there was
o apparent TRAV region, respectively. Because nei-
her TRAV-speciﬁc mAb nor strain-speciﬁc primers
ad been used for ampliﬁcation, the TRAV se-
0 and 15. (A) On day 10, hematoxylin and eosin histology reveals
all, somewhat hyperchromatic lymphocyte nuclei can be easily
l or columnar epithelial target cells they are inﬁltrating. (B) The
ncentrated at the rete-like ridges and associated with target cell
stry demonstrates that  90% of these lymphocytes express V11.
ayer by day 15 [arrow in (D); the inset represents negative staining
show V11 inﬁltration at day 10 (E) and day 15 (F)., days 1
he sm
mucosa
ore co
chemi
basal luence results were entirely representative of the
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C. G. DiRienzo et al.270nti-BALB.B miHA-speciﬁc B6 CFSElow/negative
D4V11 T cells.
xtraction of Tissue-Infiltrating B6 CD4V11
Cells by LMD
The restricted use of TRAV13 sequence by the in
itro anti-BALB.B responding B6 V11 CD4 T
ells was consistent with recognition of a limited num-
er of miHA. To establish the biological signiﬁcance
f our analysis, we performed LMD [1] to excise
estricted areas within BALB.B target tissues in an
igure 2. Evolution of B6¡BALB.B GVHD in intestinal epithelium
re noted by day 15 (B), consisting of lymphoid inﬁltration and apop
ontrol. (C) Rare V11 cells are present at day 10 (arrow), where
taining for V5 in an adjacent section. The B6¡B6 control gut fa
E) or day 15 (F).ffort to determine whether the restricted TRAV se- suences were located at sites of CD4 inﬁltration and
oncomitant GVHD-associated tissue damage. Tak-
ng the day 15 posttransplantation frozen tissue sec-
ions previously described in Figures 1 and 2, we
xcised  1-mm linear sections from areas that exhib-
ted signiﬁcant staining with the V11-speciﬁc mAb,
articularly within the RLP of the dorsal lingual epi-
helium (Figure 5A, B) and surrounding the ileal
rypts of the small intestine (Figure 5C, D). We also
erformed LMD on similar tissue samples from irra-
iated B6 mice that had only received B6 ATBM, to
10 and 15. Pathological changes are not apparent at day 10 (A) but
f crypt epithelium (arrows). The inset in (B) depicts day 15 B6¡B6
erous positive cells are present at day 15 (D). In (D), the inset is
how signiﬁcant inﬁltration by V11-positive cells at either day 10, days
tosis o
as num
ils to serve as a negative control for any potential nonspe-
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V Use in GVHD 271iﬁc inﬁltration of cells associated with the irradiation
onditioning of the recipients (Figure 5E–H).
CR Amplification of Restricted B6 TRAV
equences at the Sites of GVHD Tissue Damage
DNA was extracted from the LMD samples, and
ultiplex PCR was performed with primers designed
peciﬁcally to amplify genomic CD4 along with either
he TRAV13–TRAJ16 or TRAV13–TRAJ17 seg-
ents previously found in the in vitro experiment.
his approach was taken because TRAV–TRAJ rear-
angement already would have occurred during T-cell
evelopment in the thymus and because of the dis-
ance between the TRAJ and constant regions, making
irect cloning of such large fragments difﬁcult. In
ddition, CD4 primers were used as an internal PCR
ontrol. Because the primers for CD4 were meant to
mplify genomic DNA, the presence of CD4 was
xpected in all of the samples analyzed. Each of the
MD samples from individual mice showed the con-
rol CD4 band along with either TRAV13–TRAJ16
r TRAV13–TRAJ17 (data not shown) in both the
ingual (Figure 6A) and intestinal (Figure 6B) samples.
igure 3. Isolation of responding B6 CD4V11 T cells. B6 mice
ere serially immunized with BALB.B splenocytes (2  107, IP) on
ays 0, 17, and 42. On day 63, spleen and LN CD4 T cells from
hese mice were labeled with CFSE and cultured for 3 days with
ither L-mimosin to distinguish nondividing cells (A) or irradiated
ALB.B splenocytes that were depleted of all T cells (B). Histo-
rams, gated on CFSECD4V11T cells, indicated that most of
he allostimulated cells underwent division, marked by decreased
FSE intensity.he ATBM control samples from these tissues ampli- ted only CD4 (Figure 6C, D), indicating that the 3
RAV sequences identiﬁed were speciﬁcally involved
n CD4 cellular inﬁltration of the GVHD target
issues. In all, these tissue-speciﬁc sequence results for
RAV–TRAJ utilization were completely consistent
ith those found in the isolated divided CD4V11
cells in the in vitro CFSE experiment. Of lesser
ote, although the TRAV13–TRAJ17 sequence was
lways out of frame and could never be expressed as a
rotein, it was still speciﬁcally found in B6 T cells that
ere inﬁltrating BALB.B tissues, alongside the in-
rame TRAV13–TRAJ16 sequence.
ISCUSSION
Despite the availability of numerous miHA ex-
ressed in the host, the donor B6 CD4 T-cell allore-
ponse is limited in its TCR V diversity after trans-
lantation into BALB.B recipients [39]. Subsequent
nvestigation revealed a correlation between the V11
nd/or V2 T-cell family responses and the severity of
cute GVHD [20-22]. Our ﬁndings in the current
tudy conﬁrm the ability of B6 CD4V11T cells to
nﬁltrate both lingual and intestinal target tissue dur-
ng the course of GVHD and the restricted use of
RAV13–TRAJ16 during the in vitro proliferative
esponse of these speciﬁc T cells against BALB.B
iHA. LMD techniques were then used for in situ
nalysis of inﬁltrating B6 CD4V11 T cells to
stablish that the in vitro TRAV sequence identiﬁed
as relevant to the GVHD-associated immunopatho-
ogic response.
Inﬁltrating V11 T cells were found in both
ingual and intestinal tissues at days 10 and 15 post-
ransplantation. This ﬁnding is of interest because it is
onsistent with the known association of severe
VHD induction by V11 and/or V2 T cells
ith more detectable GVHD-related intestinal pa-
hology in BALB.B but not in CXB-2 recombinant
nbred mice [20]. The presence of CD4V11 T
ells with the identical TRAV sequence in both the
LP regions of the tongue and the ileal crypts of the
ntestine in the BALB.B recipients strongly suggests
hat the miHA recognized by these speciﬁc effector
ells are expressed in both target tissues. However,
revious studies showed that differential tissue dam-
ge mediated by B6 donor CD4 T cells was found in
he intestine of only BALB.B mice, not CXB-2 mice
20]. One possible explanation of this dichotomy is
hat BALB.B mice uniquely express the relevant
11-associated miHA in the intestine, either quali-
atively or quantitatively, which induces a more severe
nﬂammatory response that directly affects the recip-
ent’s health status. In contrast, inﬂammation in the
quamous mucosa of the tongue and, by extension, to
he general skin surface probably has less impact on
he recipient’s overall health and survival.
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C. G. DiRienzo et al.272To extend our previous repertoire analysis of B6
D4 T cells associated with GVHD responses in
ALB.B mice to the TCR chain, we sequenced re-
ponding TRAV in the CD4V11 T-cell response.
PA-PCR allowed us to enrich for -chain tran-
cripts and to sequence TRAV found within the pro-
iferating CFSE-diminished CD4V11 T cells
ithout creating primers for all of the known TRAV.
e saw a limited TRAV presence within this popu-
ation of responding cells. Sequence alignments of
hese TRAV showed a restricted use of TRAV13 com-
ined with TRAJ16. The ability to clone different
equences, including some that were out of a reading
rame (TRAJ17), indicated that our analysis was not
eing done on 1 TRAV present in the PCR mixture
igure 4. Alignment of TRAV sequences isolated from CFSE-labe
D4V11 T cells, cDNA was enriched for TCR chain transcrip
roducts were visualized on an agarose gel, gel-puriﬁed, then clon
olonies and sequences were aligned for similarity using the CLUST
atabase using the IMGT/V-QUEST program. (A) Sequence alig
ompared against CD-D16, which was used as a reference sequen
ashes represent nucleotide identity, and dots represent nucleotide
ritten in the areas that differ. CD-D16, CD-D14, CD-D2, CD-D
D-D37 CD-D1, CD-D3, and CD-D4 contain the sequences w
RAJ43. CD-D13 is an incomplete sequence and contains only TR
re included above the nucleotide sequences in the alignment. TRA
ucleotides.nd continuously ampliﬁed. The restricted use of oRAV corroborates the ﬁndings in other antigenic
ystems [8-14,41].
It is also worth noting that unlike the TCR
hain, there is no allelic exclusion for the  chain. As
result, both loci can rearrange in a developing T cell
n the thymus, and thus 2 TCR chain proteins can be
xpressed on the surface of a T cell with a single
CR chain [42,43]. This possibility emphasizes the
niqueness of the TRAV13–TRAJ16 rearrangement
s representing the only  chain that appears to inter-
ct with the as-yet unknown BALB.B MHC class
I–restricted miHA.
What appears to be a single uncharacterized
iHA able to elicit severe GVHD mediated by the
D4V11 T-cell response may be the ﬁrst to be
CD4V11 T cells. After RNA extraction from CFSElow-negative
g a NotI-C3 primer and subsequently ampliﬁed using NPA-PCR.
a pGEM T-Easy vector. DNA sequences isolated from bacteria
rogram. All sequences were compared to those found in the IMGT
of all sequences, in frame and out of frame. All sequences were
omparison with the other sequences for similarity or differences.
ucleotides that differ from the reference sequence have the letters
CD-D10 contain the sequences for TRAV13-TRAJ16. CD-D12,
AJ17. CD-D9 contains an out-of-frame sequence for TRAV13–
TRAC regions. (B) TRAV13–TRAJ16. Note that the amino acids
-region additions), TRAJ, and TRAC regions are indicated aboveled B6
ts usin
ed into
ALW p
nment
ce for c
gaps. N
6, and
ith TR
AJ and
V, N (Nbserved as such in murine models. Its existence had
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V Use in GVHD 273een previously hypothesized after a series of inter-
train GVHD studies in the B6¡BALB.B model and
etween members of the closely related recombinant
nbred CXB strains [18]. In another instance, an in-
estigation by Miconnet et al. [44] identiﬁed the
D4 V response of donor T cells in a strain com-
ination involving both miHA and strong Mtv supe-
antigen stimulation, but the contributions of the
iHA themselves were not clear [44]. Although pre-
ious studies analyzing TRAV diversity using trans-
enic mice expressing a single TCR chain had the
igure 5. LMD targeting of B6 V11 T cells in BALB.B organs.
6 CD4 T cells (2  107) and ATBM (2  106) were transferred
nto lethally irradiated (10 Gy) BALB.B or control B6 recipients.
mmunohistochemistry of uncoverslipped tissue sections stained
ith V11 antibody and counterstained with hematoxylin. (A, B)
MD-targeted areas of lingual epithelium RLP before (A) and after
B) LMD. (C, D) Targeted areas of small intestines before (C) and
fter (D) LMD. Control mice were lethally irradiated (10 Gy) and
njected with 2 106 B6 ATBM. (E, F) RLP of control mice before
E) and after (F) LMD. (G, H) Targeted intestinal areas of control
ice before (G) and after (H) LMD. Note the areas that have been
xtracted by LMD. The pictures are from 1 mouse and are repre-
entative of 2 separate experiments, each with n 
 3.eneﬁt of knowing the antigenic peptide along with coth the  and  chains, our CFSE studies circum-
ented the need to know the speciﬁc miHA being
ecognized by the CD4V11 T cells.
It is commonly held that alterations of host MHC
ype can have profound effects on the grade, target
rgans, and phenotype of GVHD [45]. Because the
HC can select a TCR repertoire by positive and
egative selection in the thymus and present different
ypes of peptides in the periphery, it seems quite
easonable to consider that the severity of GVHD in
HC-matched situations results from the types and
xpression levels of miHA peptides that speciﬁc MHC
an display [46]. Therefore, an immune response’s
ependence on TRBV versus TRAV restriction would
eem to depend on the nature of the target antigens.
n studies in which target antigens were known, vary-
ng degrees of TCR and  dependence were ob-
erved. Some systems relied on TCR conservation,
hereas others relied equally on TCR and  conser-
ation [9,11,12,41,47-49]. In comparison, in our
6¡BALB.B CD4-mediated GVHD model, with
s-yet unidentiﬁed miHA, we focused on the seem-
ngly important CD4V11 T-cell responses to ex-
mine TRAV use. The ﬁnding of a single restricted
RAV association suggests that these speciﬁc T cells
re recognizing only a single miHA, and that TRAV
nteraction is important. This observation of a re-
tricted TRAV use is also consistent with a study in a
D8 T-cell model of GVHD that suggested that
iHA recognition was dependent on peptide contact
ith the TCR chain [50].
Without having a full repertoire of murine TRAV
ntibodies available, we could not deﬁnitively deter-
ine whether the in vitro identiﬁed and sequenced
RAV from the CFSE-labeled CD4V11 T cells
ere actually expressed on the cell surface. To provide
vidence that the observed TRAV restriction was rel-
vant to the in vivo GVHD situation, at sites of tissue
estruction we isolated tissue sections containing the
nﬁltrating V11 T cells using LMD. The exact
RAV13–TRAJ16 sequence was found within the lin-
ual and intestinal GVHD-afﬂicted BALB.B tissues.
he sequence for the out-of-frame TRAV13–TRAJ17
earrangement was also found in equal proportion, as
n the CFSE experiment. This could imply a possible
reference for TRAV13 to combine with TRAJ16 or
RAJ17. The 2 TRAJ gene segments are situated
djacent to each other on their locus, and some studies
ave reported a preference of TRAV for certain
RAJs, depending on their distance and accessibility
o one another [51-54].
It also should be noted that although NPA-PCR
llowed us to sequence  chains without knowing the
ariable region, this method did not allow us to se-
uence the entire TRAV region, so we could not
ntirely distinguish between TRAV subfamilies. It is
ertain that the single most prevalent in-frame TRAV
s
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C. G. DiRienzo et al.274equence was TRAV13, but because subfamilies have 
5% homology, further identiﬁcation was difﬁcult.
he apparent absence of the other 5 V families in the
FSE-reactive population, previously observed to be
kewed in the spleens of BALB.B mice undergoing
VHD, could result from the absence of those spec-
ﬁcities in the target tissue inﬁltrate and/or the result
f multiple presensitization of the donor B6 mice with
ALB.B splenocytes, focusing the T-cell response to-
ard a more dominant miHA.
Considering the immense diversity found within
he repertoire of TCR chains, the restricted response
dentiﬁed during the B6 CD4V11T-cell response
mplies that a strong selective pressure may be acti-
ating a limited number of T cells expressing partic-
lar  and  chains. We postulate that this selective
ressure may be in the form of a limited number of
mmunodominant miHA that elicit the B6-mediated
VHD reaction and are responsible for the patholog-
cal severity in the BALB.B recipients [17,45,55-57].
he present study has extended our understanding of
his limited T-cell repertoire response to the TCR 
hain as well.
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